Related references
Note: Only part of the references are listed.Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors
Max Loehning et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies
Andreas Wortmann et al.
MOLECULAR THERAPY (2008)
Decreased tumor surveillance after adoptive T cell therapy
Matthias Matter et al.
CANCER RESEARCH (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity
Barry S. Peters et al.
VACCINE (2007)
Prevalence of antibodies to lymphocytic choriomeningitis virus in blood donors in southeastern France
Xavier de Lamballerie et al.
TRANSFUSION (2007)
Transmission of lymphocytic choriomeningitis virus by organ transplantation.
Staci A. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant
B Bellier et al.
VACCINE (2006)
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA
L Flatz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus
P Krebs et al.
JOURNAL OF IMMUNOLOGY (2005)
Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys
MS Seaman et al.
JOURNAL OF VIROLOGY (2005)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Kinetics of protective antibodies are determined by the viral surface antigen
DD Pinschewer et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression
HC Probst et al.
JOURNAL OF IMMUNOLOGY (2003)
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses
K Loré et al.
JOURNAL OF IMMUNOLOGY (2003)
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein
DD Pinschewer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Lymphocytic choriomeningitis virus infection in a province of Spain:: Analysis of sera from the general population and wild rodents
L Lledó et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance
HC Probst et al.
IMMUNITY (2003)
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory
D Homann et al.
NATURE MEDICINE (2001)
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection
C Pope et al.
JOURNAL OF IMMUNOLOGY (2001)
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
N Sevilla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue
D Valmori et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
